Distribution and Characteristics of Bacteria Isolated from Cystic Fibrosis Patients with Pulmonary Exacerbation

Background. Cystic fibrosis (CF) is an inherited recessive disorder characterized by recurrent and persistent pulmonary infections, resulting in lung function deterioration and early mortality. Methods. A cross-sectional study was conducted on the bacterial profile and antibiotic resistance pattern...

Full description

Bibliographic Details
Published in:	Canadian Journal of Infectious Diseases and Medical Microbiology
Main Authors:	Soroor Erfanimanesh, Mohammad Emaneini, Mohammad Reza Modaresi, Mohammad Mehdi Feizabadi, Shahnaz Halimi, Reza Beigverdi, Vajiheh Sadat Nikbin, Fereshteh Jabalameli
Format:	Article
Language:	English
Published:	Wiley 2022-01-01
Online Access:	http://dx.doi.org/10.1155/2022/5831139

Similar Items

Phylogenetic group, antibiotic resistance, virulence gene, and genetic diversity of Escherichia coli causing bloodstream infections in Iran
by: Saeed Hemati, et al.
Published: (2024-07-01)

Determining effects of nitrate, arginine, and ferrous on antibiotic recalcitrance of clinical strains of Pseudomonas aeruginosa in biofilm-inspired alginate encapsulates
by: Fereshteh Jabalameli, et al.
Published: (2023-07-01)

Acinetobacter baumannii infection in critically ill patients with COVID-19 from Tehran, Iran: the prevalence, antimicrobial resistance patterns and molecular characteristics of isolates
by: Mahsa Ghamari, et al.
Published: (2025-01-01)

In Vitro antibiotic combinations of Colistin, Meropenem, Amikacin, and Amoxicillin/clavulanate against multidrug-resistant Klebsiella pneumonia isolated from patients with ventilator-associated pneumonia
by: Ghazal Bayatinejad, et al.
Published: (2023-10-01)

Phenotypic and genotypic evaluation of aminoglycoside resistance in Escherichia coli isolated from patients with blood stream infections in Tehran, Iran
by: Mahsa Ghamari, et al.
Published: (2024-04-01)

Molecular investigation of Staphylococcus aureus isolated from the patients, personnel, air and environment of an ICU in a hospital in Tehran
by: Mehdi Mirzaii, et al.
Published: (2015-03-01)

Characterization of biofilm formation, antimicrobial resistance, and staphylococcal cassette chromosome mec analysis of methicillin resistant Staphylococcus hominis from blood cultures of children
by: Setareh Soroush, et al.

Nasal carriage rate of methicillin resistant Staphylococcus aureus among Iranian healthcare workers: a systematic review and meta-analysis
by: Mohammad Emaneini, et al.

Global prevalence and antibiotic resistance in clinical isolates of Stenotrophomonas maltophilia: a systematic review and meta-analysis
by: Maryam Banar, et al.
Published: (2023-05-01)

Clonal relation and antimicrobial resistance pattern of extended-spectrum β-lactamase- and AmpC β-lactamase-producing Enterobacter spp. isolated from different clinical samples in Tehran, Iran
by: Roya Ghanavati, et al.

Evaluation of Mannosidase and Trypsin Enzymes Effects on Biofilm Production of Pseudomonas aeruginosa Isolated from Burn Wound Infections.
by: Maryam Banar, et al.
Published: (2016-01-01)

Psychometric Properties of the Persian Version of Cystic Fibrosis Questionnaire: Revised in Children with Cystic Fibrosis
by: Naser Havaei, et al.
Published: (2023-06-01)

Acute hyperglycaemia in cystic fibrosis pulmonary exacerbations
by: Lina Merjaneh, et al.
Published: (2021-04-01)

The impact of probiotics on pulmonary, gastrointestinal, and growth outcomes in pediatric cystic fibrosis: a randomized controlled trial
by: Parisa Rahmani, et al.
Published: (2025-05-01)

Evaluation of Copeptin during Pulmonary Exacerbation in Cystic Fibrosis
by: I. Wojsyk-Banaszak, et al.
Published: (2019-01-01)

Airway inflammation accelerates pulmonary exacerbations in cystic fibrosis
by: Theodore G. Liou, et al.
Published: (2024-03-01)

Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis
by: Akhil Sawant, et al.
Published: (2018-01-01)

Lung ultrasound for the diagnosis of cystic fibrosis pulmonary exacerbation
by: Maryam Hassanzad, et al.
Published: (2021-11-01)

Extracellular vesicles in sputum of children with cystic fibrosis pulmonary exacerbations
by: Elad Ben-Meir, et al.
Published: (2024-12-01)

Occurrence of COVID-19 in cystic fibrosis patients: a review
by: Fatemeh Sadat Abolhasani, et al.
Published: (2024-04-01)

Evaluating the efficacy of inhaled amikacin as an adjunct to intravenous combination therapy (ceftazidime and amikacin) in pediatric cystic fibrosis pulmonary exacerbation
by: Amin Rakhshan, et al.
Published: (2023-03-01)

The effects of aerobic exercises compared to conventional chest physiotherapy on pulmonary function, functional capacity, sputum culture, and quality of life in children and adolescents with cystic fibrosis: a study protocol for randomized controlled trial study
by: Nadia Hamedi, et al.
Published: (2023-10-01)

Investigation of some anaerobic bacteria in the sputum of cystic fibrosis patients and healthy people in Tehran, Iran
by: Homa Hamayeli, et al.
Published: (2024-07-01)

BEAT CF pulmonary exacerbations core protocol for evaluating the management of pulmonary exacerbations in people with cystic fibrosis
by: Andre Schultz, et al.
Published: (2023-03-01)

Definitions of pulmonary exacerbation in people with cystic fibrosis: a scoping review
by: Malcolm Brodlie, et al.
Published: (2024-08-01)

Metabolomics of pulmonary exacerbations reveals the personalized nature of cystic fibrosis disease
by: Robert A. Quinn, et al.
Published: (2016-08-01)

Determination of carbapenem resistance mechanism in clinical isolates of Pseudomonas aeruginosa isolated from burn patients, in Tehran, Iran
by: Akbar Mirsalehian, et al.
Published: (2017-04-01)

Evaluation of the β-Lactamase Disk Test Method in the Detection of Extended-Spectrum-β-Lactamases in Clinical Isolates of Multidrug-Resistant Pseudomonas aeruginosa
by: Davood Kalantar-Neyestanaki Kalantar-Neyestanaki, et al.
Published: (2016-01-01)

Determination of carbapenem resistance mechanism in clinical isolates of Pseudomonas aeruginosa isolated from burn patients, in Tehran, Iran
by: Akbar Mirsalehian, et al.
Published: (2019-04-01)

Influence of Fungal Colonization on Exacerbations in Patients with Cystic Fibrosis
by: Claudia Janeth Madrid-Carbajal, et al.
Published: (2024-12-01)

Evaluation of Antimicrobial Susceptibility Patterns of Enterococci Isolated from Patients in Tehran University of Medical Sciences Teaching Hospitals
by: Fereshteh Jabalameli, et al.
Published: (2009-08-01)

Vancomycin Monitoring for Treatment of Acute Pulmonary Exacerbations of Adult Cystic Fibrosis Patients
by: Darrell Smith, et al.
Published: (2025-01-01)

Is there a role of viral infection in cystic fibrosis exacerbation in children?
by: Dina H Hamed, et al.
Published: (2022-06-01)

Urinary bicarbonate and metabolic alkalosis during exacerbations in cystic fibrosis
by: Giulia Spoletini, et al.
Published: (2022-05-01)

Identification and characterization of bacteria isolated from patients with cystic fibrosis in Jordan
by: Nid’a Alshraiedeh, et al.
Published: (2022-12-01)

Plasma sCD14 as a biomarker to predict pulmonary exacerbations in cystic fibrosis.
by: Bradley S Quon, et al.
Published: (2014-01-01)

The Fitter the Better? Cardiopulmonary Exercise Testing Can Predict Pulmonary Exacerbations in Cystic Fibrosis
by: Asterios Kampouras, et al.
Published: (2021-06-01)

Pulmonary Exacerbations in Pediatric Patients: Retrospective Study in a Portuguese Cystic Fibrosis Center
by: Rosa Cardoso, et al.
Published: (2022-01-01)

Smartphone-Based pH Sensor for Home Monitoring of Pulmonary Exacerbations in Cystic Fibrosis
by: Alexander Sun, et al.
Published: (2017-05-01)

Association between sputum culture results and pulmonary changes in children with cystic fibrosis
by: Fatemeh Khani Nozari, et al.
Published: (2023-11-01)